Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Oncolytics Biotech, Inc.
(NQ:
ONCY
)
2.670
USD
+0.030 (+1.14%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Oncolytics Biotech, Inc.
< Previous
1
2
3
4
Next >
Oncolytics Biotech (ONCY) Posts Q1 Loss of 8c/Share
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8320336 for the full story.
Read More
from
StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 03/28: (RPRX) (DECK) (XONE) Higher; (FIVE) (RHT) (GME) Lower (more...)
March 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8217417 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics (ONCY) REOLYSIN Met Primary Endpoint in Phase 2 on SCCLC
March 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8216741 for the full story.
Read More
from
StreetInsider.com News Articles
ONC.CA Makes Notable Cross Below Critical Moving Average
March 13, 2013
In trading on Wednesday, shares of Oncolytics Biotech Incorporated (ONC) crossed below their 200 day moving average of $3.08, changing hands as low as $3.06 per share. Oncolytics Biotech Incorporated...
Read More
category
Dividends
from
Dividend Channel
Oncolytics (ONCY) Completes Enrollment in REOLYSIN Phase 2
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8155035 for the full story.
Read More
from
StreetInsider.com News Articles
Eleven Stocks Expected to Rise by 50% to 100% — or More
March 05, 2013
DailyFinance.com : Investors are always looking for new ideas. Now that the Dow Jones Industrial Average is trying to hit new highs and investors are pouring record inflows of capital into stocks,...
Read More
category
sqnm
,
btu
,
for
, and 8 more.
from
DailyFinance.com
Piper Jaffray Starts Oncolytics Biotech (ONCY) at Overweight
March 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8150296 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Closes 8M Offering; Realizes Gross Proceeds of $32M
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8128727 for the full story.
Read More
from
StreetInsider.com News Articles
Biotech Movers: Chelsea Doubles, Vivus Dips
February 25, 2013
Read More
category
NASDAQ:INFI
,
NASDAQ:CHTP
,
Hot Stocks
, and 3 more.
from
InvestorPlace - Latest Headlines
Unusual 11 Mid-Day Movers 02/20: (CHTP) (NTSP) (LZB) Higher; (HNR) (MM) (ANAD) Lower
February 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8115921 for the full story.
Read More
from
StreetInsider.com News Articles
Mixed Open Over Economic Data
February 20, 2013
Merger and acquisition news tempered disappointment with a larger than expected drop in January housing starts. The markets opened mixed with the Dow rising 11 points to 14,046 while Nasdaq lost 5...
Read More
category
Market News
from
MarketMinute.com Market Updates
StreetInsider.com Pre-Open Movers 02/20: (CHTP) (NTSP) (DMD) Higher; (HNR) (MM) (ONCY) Lower (more...)
February 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8115127 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Prices 8M Shares at $4 (Halted)
February 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8115005 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech, Inc. (ONCY) trading halted with news pending
February 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8114999 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) to Offer Common Stock
February 19, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8112232 for the full story.
Read More
from
StreetInsider.com News Articles
Ubika Research’s Daily Canadian Box Score: Top Junior Diversified Mining (TSX VENTURE: BEX) Stock Gained 17%
February 14, 2013
from
ACCESSWIRE
Lower Close After Six Weeks Of Gains
February 11, 2013
The markets ended the day little changed with the Dow slipping 21 points to 13,971 after six weeks of gains. Nasdaq edged down a point to 3192.
Read More
category
Market News
from
MarketMinute.com Market Updates
Ubika Research’s Daily Canadian Box Score: Top Junior Diversified Mining (TSX VENTURE: GPH) Stock Gained 24%
February 11, 2013
from
ACCESSWIRE
Unusual 11 Mid-Day Movers 02/08: (CZR) (ONCY) (LNKD) Higher; (ETRM) (MSON) (GUID) Lower
February 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8074314 for the full story.
Read More
from
StreetInsider.com News Articles
24/7 Wall St. Closing Bell — February 8, 2013: Markets Start Higher, Hold on to Gains (DIS, CS, ARMH, BIIB, DFS, ATVI, CSTR, LNKD, RVBD, SPWR, AOL, APO, MCO, CCJ, L, NAT, WPP, ZNGA, ONCY, CZR)
February 08, 2013
DailyFinance.com : U.S. equity markets opened higher this morning boosted by higher-than-expected trade balances in China (more coverage here) and in the U.S. (more coverage here). In Europe the big...
Read More
category
atvi
,
apo
,
nat
, and 18 more.
from
DailyFinance.com
Oncolytics Biotech (ONCY) dips on clinical trial results
February 08, 2013
Oncolytics Biotech Inc. (NASDAQ: ONCY) shares slipped 1.9% to $3.57, after it announced results examining percent overall tumour shrinkage data from its U.S. Phase 2 clinical trial in patients with...
Read More
from
BAYSTREET RSS FEED
Trade Deficit Narrows, Markets Open Higher
February 08, 2013
The nation's trade deficit narrowed more than expected in December to boost the markets to a higher open with the Dow gaining 67 points to 14,011. Nasdaq climbed 27 points to 3192.
Read More
category
Market News
from
MarketMinute.com Market Updates
StreetInsider.com Pre-Open Movers 02/08: (ATVI) (LNKD) (AOL) Higher; (RVBD) (NUAN) (CSTR) Lower (more...)
February 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8073664 for the full story.
Read More
from
StreetInsider.com News Articles
US STOCKS-Wall St to open higher after positive economic data
February 08, 2013
NEW YORK, Feb 8 (Reuters) - U.S. stock index were set for a slightly higher open on Friday after a trio of positive economic data points, but gains were expected to be modest, with the benchmark S&P...
Read More
category
companyNews
from
Reuters: Company News
BRIEF-U.S. shares of Oncolytics jump 44 pct in premarket
February 08, 2013
NEW YORK, Feb 8 (Reuters) - Oncolytics: * U.S. shares of Oncolytics Biotech Inc jump 44 percent in premarket
Read More
category
companyNews
from
Reuters: Company News
CANADA STOCKS-TSX may open lower, jobs and trade data eyed
February 08, 2013
Feb 8 (Reuters) - Canada's main stock index futures pointed to a slightly lower open on Friday, despite encouraging Chinese trade data that set the scene for economic recovery. Canadian jobs and...
Read More
category
companyNews
from
Reuters: Company News
A Peek Into The Market Before The Trading Starts
February 08, 2013
Pre-open movers US stock futures are mostly flat this morning, as investors are awaiting trade data. Futures for the Dow Jones Industrial Average dropped 1 point to 13,897.00 and S&P 500 index futures...
Read More
category
LH
,
Benzinga
,
ONCY
, and 12 more.
from
Latest Articles from Benzinga.com
Oncolytics Biotech Announces Additional Positive Phase 2 REOLSYIN Clinical Trial Data
February 08, 2013
Oncolytics Biotech (NASDAQ: ONCY ) today announced results examining percent overall tumour shrinkage data from its U.S. Phase 2 clinical trial in patients with squamous cell carcinoma of the lung...
Read More
category
Management
,
Benzinga
,
ONCY
, and 3 more.
from
Latest Articles from Benzinga.com
Oncolytics (ONCY) Reports Encouraging Update from REOLYSIN Phase 2
February 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8073028 for the full story.
Read More
from
StreetInsider.com News Articles
Major Breakthrough in Lung Cancer Study — Treatment or Cure? (ONCY)
February 08, 2013
DailyFinance.com : Oncolytics Biotech Inc. (NASDAQ: ONCY) just reasserted its position on the map again. The company has announced test results showing tumor shrinkage data from its U.S. Phase II...
Read More
category
ONCY
from
DailyFinance.com
< Previous
1
2
3
4
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here